تحضير وتقييم حاملات الدهون النانوية للبيداكويلين – التقييم في المختبر والتنبؤ بالسيليكو

Wang MG., Wu SQ., and He JQ. Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 2021; 21(1):970. DOI: https://doi.org/10.1186/s12879-021-06666-8

Deshkar AT., Shirure PA. Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis. Cureus. 2022; 14(8):e28519. DOI: https://doi.org/10.7759/cureus.28519

Palomino JC., Martin A. Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014; 3(3):317–40. DOI: https://doi.org/10.3390/antibiotics3030317

Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: an update. Arch. Toxicol. 2016; 90:1585–1604. DOI: https://doi.org/10.1007/s00204-016-1727-6

Rxlist (2022) Sirturo (Bedaquiline Tablets): Uses, Dosage, Side Effects, Interactions, Warning.

https://www.rxlist.com/sirturo-drug.htm. Accessed 11 Aug 2022

DrugBank Online (2022). Carbidopa: Uses, Interactions, Mechanism of Action

https://go.drugbank.com/drugs/DB00190. Accessed 11 Aug 2022

Mayoclinic (2022) .drg-20060714 @

https://www.mayoclinic.org.Accessed 11 Aug 2022.

McLeay SC., Vis P.,Van Heeswijk RPG., and Green B. Population pharmacokinetics of bedaquiline (TMC207), a novel antituberculosis drug. Antimicrob Agents Chemother. 2014; 58(9):5315–5324.

Rein MJ., Renouf M., Cruz-Hernandez C., Actis-Goretta L., Thakkar SK., and da Silva Pinto M. Bioavailability of bioactive food compounds: A challenging journey to bioefficacy. Br. J. Clin. Pharmacol. 2013;75(3):588–602. DOI: https://doi.org/10.1111/j.1365-2125.2012.04425.x

De Matteis L., Jary D., Lucía A., García-Embid S., Serrano-Sevilla I., Pérez D., Ainsa JA., Navarro FP., and M. de la Fuente J. New active formulations against M. tuberculosis: Bedaquiline encapsulation in lipid nanoparticles and chitosan nanocapsules. Chem. Eng. J. 2018; 340:181–191. DOI: https://doi.org/10.1016/j.cej.2017.12.110

Abudayah, A. A. F. Implication of Nanotechnology for Pulmonary Delivery of Docetaxel. Jordan J Pharm Sci. 2023; 16(2): 470.

https://doi.org/10.35516/jjps.v16i2.1527 DOI: https://doi.org/10.35516/jjps.v16i2.1527

Chandrashekar H., and Bhattacharyya S. Statistical optimization amalgamated approach on formulation development of nano lipid carrier loaded hydrophilic gel of fluticasone propionate. Indian J Pharm. Educ. Res. 2021;55:418–427. DOI: https://doi.org/10.5530/ijper.55.2.79

Gilani SJ., Bin Jumah MN., Zafar A., Imam SS., Yasir M., Khalid M., Alshehri S., Ghuneim MM., and Albohairy FM. Formulation and Evaluation of Nano Lipid Carrier-Based Ocular Gel System: Optimization to Antibacterial Activity. Gels. 2022;8(5):255. DOI: https://doi.org/10.3390/gels8050255

Das S., Ng WK., and Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur. J Pharm. Sci. 2012; 47(1):139–151. DOI: https://doi.org/10.1016/j.ejps.2012.05.010

Negi LM., Jaggi M., and Talegaonkar S. Development of a protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers. Int. J. Pharm. 2014; 30;461(1-2):403–410. DOI: https://doi.org/10.1016/j.ijpharm.2013.12.006

Bhattacharyya S., Mohan A., and V Sandur R. Use Of Rp-Hplc For The Analytical Method Development Of Anti-Tubercular Drug- Bedaquiline. J. Pharm. Negat. Results. 2022; 13:284–290. DOI: https://doi.org/10.47750/pnr.2022.13.S05.40

Chauhan MK., and Sharma PK. Optimization and characterization of rivastigmine nanolipid carrier loaded transdermal patches for the treatment of dementia. Chem. Phys. Lipids. 2019;224:104794. DOI: https://doi.org/10.1016/j.chemphyslip.2019.104794

Subramaniam B., Siddik ZH., and Nagoor NH. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J. Nanoparticle Res. 2020; 22:141 DOI: https://doi.org/10.1007/s11051-020-04848-0

Saghafi Z., Mohammadi M., Mahboobian MM., and Derakhshandeh K. Preparation, characterization, and in vivo evaluation of perphenazine-loaded nanostructured lipid carriers for oral bioavailability improvement. Drug Dev. Ind. Pharm. 2021; 47(3):509–520. DOI: https://doi.org/10.1080/03639045.2021.1892745

Bharadwaj R., Das PJ., Pal P., and Mazumder B. Topical delivery of paclitaxel for treatment of skin cancer. Drug Dev. Ind. Pharm. 2016;42(9):1482–94. DOI: https://doi.org/10.3109/03639045.2016.1151028

Reddy H V R., Bhattacharyya S., and HR K. Optimization of process parameters for emulsion solvent evaporation technique in the preparation of nano lipid carriers using definitive screening design. Int. J. Pharm. Res. 2019;11(1):719–726

Barakat N., Jaber M., and AlKhatib HS. Preparation, in vitro and in vivo evaluation of solid-in-oil dispersion-based formulation the anti-glaucoma drug, timolol maleate. Jordan J Pharm Sci. 2023; 16(2): 476. https://doi.org/10.35516/jjps.v16i2.1533F DOI: https://doi.org/10.35516/jjps.v16i2.1533

Mahmood A., Khan L., Ijaz M., Nazir I., Naseem M., Tahir MA., Aamir MN., Rehman MU., and Asim MH. Drug Delivery System: In-Vitro and Ex-Vivo Characterization. Molecules. 2023; 28(6):2827. DOI: https://doi.org/10.3390/molecules28062827

Adwan G. In vitro Assessment of Antibacterial Activity and Potential Genotoxic Effect of Fruit Extracts of Capparis spinosa L. Plant. Jordan J Pharm Sci.2023; 16(2): 322–329.

https://doi.org/10.35516/jjps.v16i2.517 DOI: https://doi.org/10.35516/jjps.v16i2.517

Lyu XL., Lin TT., Gao JT., Jia HY., Zhu CZ., Li ZH., Dong J., Sun Q., Shu W., Wang SS., Pan LP., Huang HR., Zhang Z De., and Li Q. Effects of Bedaquiline on Antimicrobial Activity and Cytokine Secretion of Macrophages Infected with Multidrug-Resistant Mycobacterium tuberculosis Strains. Can. J. Infect. Dis. Med. Microbiol. 2022; 2703635 DOI: https://doi.org/10.1155/2022/2703635

Hu Y., and Smith DE. In silico prediction of the absorption and disposition of cefadroxil in humans using an intestinal permeability method scaled from humanized pept1 mice . Drug Metab. Dispos. 2019;47(3):173–83. DOI: https://doi.org/10.1124/dmd.118.084236

Sjögren E., Thörn H., and Tannergren C. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models. Mol. Pharm. 2016;13(6):1763–78. DOI: https://doi.org/10.1021/acs.molpharmaceut.5b00861

McLeay SC., Vis P., Van Heeswijk RPG., and Green B. Population pharmacokinetics of bedaquiline (TMC207), a novel antituberculosis drug. Antimicrob. Agents Chemother. 2014; 58:5315–5324. DOI: https://doi.org/10.1128/AAC.01418-13

Bhattacharyya S., and Sogali BS. Application of Statistical Design to Assess the Critical Process Parameters of Ethanol Injection Method for the Preparation of Liposomes. Dhaka Univ. J. Pharm. Sci. 2019; 18(1): 103 111. DOI: https://doi.org/10.3329/dujps.v18i1.41897

Glycerol dibehenate | IMCD (imcdgroup.com) https://www.imcdgroup.com/en/business-groups/pharmaceuticals/solution-centre/glycerol-dibehenate-excipients-topicals-lotion-viscosifier

Bhattacharyya S., Sudheer P., Das K., and Ray S. Experimental design supported liposomal aztreonam delivery: In Vitro studies. Adv. Pharm. Bull. 2021; 11(4): 651–662. DOI: https://doi.org/10.34172/apb.2021.074

Lin L., and Wong H. Predicting oral drug absorption: Mini review on physiologically-based pharmacokinetic models. Pharmaceutics.2017; 9(4):41. DOI: https://doi.org/10.3390/pharmaceutics9040041